3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
4
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mastocytosis
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Methylphenidate
2
Methods
2
sargramostim
1
ropidoxuridine
1
entrectinib
1
entinostat
1
cc-486
1
carboxyamido-triazole
1
bintrafusp alfa protein, human
1
Watchful Waiting
1
WP 744
1
Vincristine
1
Thalidomide
1
Temozolomide
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Psychology, Positive
1
Psychiatric Rehabilitation
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Observation
1
O(6)-benzylguanine
1
N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide
1
Molecular Diagnostic Techniques
1
Megestrol Acetate
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Watchful Waiting
×
Other hematologic neoplasm
×
Clear all
NCT05375617
2026-06-02
EPICkids
Columbia University
Recruiting
1,400 enrolled